1,299 followers
RT @FrontOncology: New research: Tislelizumab induced dual organs dysfunction in a patient with advanced esophageal squamous cell carcinoma…
RT @FrontOncology: New research: Tislelizumab induced dual organs dysfunction in a patient with advanced esophageal squamous cell carcinoma…
RT @FrontOncology: New research: Tislelizumab induced dual organs dysfunction in a patient with advanced esophageal squamous cell carcinoma…
New research: Tislelizumab induced dual organs dysfunction in a patient with advanced esophageal squamous cell carcinoma: a case report: Background Tislelizumab, a humanized IgG4 anti-PD-1 monoclonal antibody has been approved in China and… https://t.co/P